This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1969 Sep;23(3):587-90.

doi: 10.1038/bjc.1969.72.

Tumorigenicity of acridine orange

B L Van Duuren, A Sivak, C Katz, S Melchionne

PMID: 4902593
PMCID: PMC2008414
DOI: 10.1038/bjc.1969.72

Free PMC article

Tumorigenicity of acridine orange

B L Van Duuren et al. Br J Cancer. 1969 Sep.

Free PMC article

. 1969 Sep;23(3):587-90.

doi: 10.1038/bjc.1969.72.

Authors

B L Van Duuren, A Sivak, C Katz, S Melchionne

PMID: 4902593
PMCID: PMC2008414
DOI: 10.1038/bjc.1969.72

No abstract available

PubMed Disclaimer

Similar articles

The induction of malignant lymphomas and other tumors by 7,12-dimethylbenz(a)anthracene in the Syrian golden hamster.
Toth B. Toth B. Cancer Res. 1969 Aug;29(8):1476-84. Cancer Res. 1969. PMID: 4896901 No abstract available.
Carcinogenicity of tetraethyl lead.
Epstein SS, Mantel N. Epstein SS, et al. Experientia. 1968 Jun 15;24(6):580-1. doi: 10.1007/BF02153784. Experientia. 1968. PMID: 4301539 No abstract available.
Carcinogenic activity of 5-hydroxy-3,4-benzopyrene.
Nagata C, Tagashira Y, Inomata M, Kodama M. Nagata C, et al. Gan. 1971 Oct;62(5):419-21. Gan. 1971. PMID: 5140790 No abstract available.
Cutaneous manifestations of methotrexate-associated lymphoproliferative disorders: report of two cases and a review of the literature.
Shimizu S, Inokuma D, Murata J, Kikuchi K, Ito T, Fukasawa Y, Mukai M, Moriuchi R. Shimizu S, et al. Acta Derm Venereol. 2015 Mar;95(3):366-7. doi: 10.2340/00015555-1951. Acta Derm Venereol. 2015. PMID: 25138609 Review. No abstract available.
Aziridine.
[No authors listed] [No authors listed] IARC Monogr Eval Carcinog Risk Chem Man. 1975;9:37-46. IARC Monogr Eval Carcinog Risk Chem Man. 1975. PMID: 186395 Review. No abstract available.

See all similar articles

Cited by

Genetic mode of action of cocarcinogens and tumor promoters in yeast and mice.
Fahrig R. Fahrig R. Mol Gen Genet. 1984;194(1-2):7-14. doi: 10.1007/BF00383490. Mol Gen Genet. 1984. PMID: 6374383
Interactions of histone, ribonuclease and acridine orange in enhancing film sarcoma.
Lavelle SM, Maclomhair M. Lavelle SM, et al. Ir J Med Sci. 1983 Jul;152(7):272-5. doi: 10.1007/BF02954796. Ir J Med Sci. 1983. PMID: 6618833 No abstract available.
Miracil D: inhibition of deoxyribonucleic acid polymerase-deficient Escherichia coli.
Rosenkranz HS. Rosenkranz HS. Antimicrob Agents Chemother. 1973 Apr;3(4):530-1. doi: 10.1128/AAC.3.4.530. Antimicrob Agents Chemother. 1973. PMID: 4597728 Free PMC article.
Acridine Orange: A Review of Novel Applications for Surgical Cancer Imaging and Therapy.
Byvaltsev VA, Bardonova LA, Onaka NR, Polkin RA, Ochkal SV, Shepelev VV, Aliyev MA, Potapov AA. Byvaltsev VA, et al. Front Oncol. 2019 Sep 24;9:925. doi: 10.3389/fonc.2019.00925. eCollection 2019. Front Oncol. 2019. PMID: 31612102 Free PMC article. Review.
Differences between drosophila melanogaster and its sibling species D. simulans in sensitivity to acridine orange treatment.
Alba P, Ferrés MD, Xamena N, Creus A, Marcos R. Alba P, et al. Experientia. 1983 Mar 15;39(3):300-1. doi: 10.1007/BF01955315. Experientia. 1983. PMID: 6402376

See all "Cited by" articles

References

1. Biochem Pharmacol. 1964 Feb;13:263-7 - PubMed
1. Nature. 1968 Jul 27;219(5152):385-7 - PubMed
1. Nature. 1966 Apr 9;210(5032):205-6 - PubMed
1. Cancer Res. 1968 Nov;28(11):2349-56 - PubMed
1. Ann Inst Pasteur (Paris). 1966 Oct;111(4):427-36 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources